4//SEC Filing
Ouzren Nawal 4
Accession 0001209191-21-012209
CIK 0001080709other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 9:02 PM ET
Size
14.8 KB
Accession
0001209191-21-012209
Insider Transaction Report
Form 4
Ouzren Nawal
Director
Transactions
- Award
Common Stock
2021-02-12+893→ 893 total - Award
Common Stock
2021-02-12+595→ 1,488 total - Award
Stock Option (right to buy)
2021-02-12+2,500→ 2,500 totalExercise: $83.95Exp: 2028-02-12→ Common Stock (2,500 underlying) - Award
Stock Option (right to buy)
2021-02-12+1,666→ 1,666 totalExercise: $83.95Exp: 2028-02-12→ Common Stock (1,666 underlying)
Footnotes (4)
- [F1]The amount represents restricted stock units that vest in three equal installments on the dates of Arena's next three annual meetings of stockholders. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.
- [F2]The amount represents restricted stock units that vest in full on the date of Arena's 2021 annual meeting of stockholders. The shares underlying the restricted stock units will be issued upon vesting and release of the restricted stock units.
- [F3]The options vest in 36 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over three years beginning on March 12, 2021, and are exercisable once vested.
- [F4]The options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on March 12, 2021, and are exercisable once vested.
Issuer
ARENA PHARMACEUTICALS INC
CIK 0001080709
Entity typeother
Related Parties
1- filerCIK 0001846836
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 9:02 PM ET
- Size
- 14.8 KB